Fengtian Sun, Yuntong Sun, Feng Wu, Wenrong Xu, & Hui Qian. (2022). Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapy for Diabetes Mellitus and Diabetic Complications. MDPI AG.
Chicago Style (17th ed.) CitationFengtian Sun, Yuntong Sun, Feng Wu, Wenrong Xu, and Hui Qian. Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapy for Diabetes Mellitus and Diabetic Complications. MDPI AG, 2022.
MLA (9th ed.) CitationFengtian Sun, et al. Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapy for Diabetes Mellitus and Diabetic Complications. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.